Adults with hypoparathyroidism treated with TransCon PTH in the phase 3 PaTHway open-label trial extension demonstrated ...
Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback